Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
0.4787
Nov 20 • 3:59 PM ET Dollar change-0.0023 Percentage change(-0.48%)
Aftermarket Close
0.4650
Aftermarket • 5:37 PM ET Dollar change-0.0137 Percentage change(-2.86%)
Index
-
Market Cap
17.59M
Enterprise Value
-23.73M
Income
-24.83M
Sales
0.00M
Book/sh
1.31
Cash/sh
1.12
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
5
IPO
Sep 15, 2021
P/E
-
Forward P/E
-
PEG
-
P/S
-
P/B
0.37
P/C
0.43
P/FCF
-
EV/EBITDA
-
EV/Sales
-
Quick Ratio
15.67
Current Ratio
15.67
Debt/Eq
0.00
LT Debt/Eq
0.00
Option/Short
No / Yes
EPS (ttm)
-1.37
EPS next Y
-0.46
EPS next Q
-0.21
EPS this Y
73.88%
EPS next Y
39.47%
EPS next 5Y
42.61%
EPS past 3/5Y
35.92% -117.71%
Sales past 3/5Y
- -
EPS Y/Y TTM
73.07%
Sales Y/Y TTM
-
EPS Q/Q
51.75%
Sales Q/Q
-
Insider Own
3.59%
Insider Trans
133.95%
Inst Own
55.91%
Inst Trans
-6.53%
ROA
-82.61%
ROE
-88.78%
ROIC
-56.78%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
SMA20
0.23%
SMA50
1.48%
SMA200
-20.87%
Trades
Shs Outstand
36.75M
Shs Float
35.43M
52W High
2.06 -76.76%
52W Low
0.28 70.36%
Volatility
17.03% 17.82%
ATR (14)
0.07
RSI (14)
49.50
Beta
0.25
Rel Volume
0.14
Avg Volume
700.16K
Volume
100,725
Perf Week
-8.30%
Perf Month
7.52%
Perf Quarter
-5.21%
Perf Half Y
-31.59%
Perf YTD
-62.89%
Perf Year
15.32%
Perf 3Y
-92.55%
Perf 5Y
-98.99%
Perf 10Y
-
Prev Close
0.48
Price
0.48
Change %
-0.48%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coastlands Capital LP10% OwnerNov 17 '26Buy0.47875,000411,2505,502,549Nov 17 08:42 PM
Coastlands Capital LP10% OwnerNov 16 '26Buy0.50583,083290,9004,627,549Nov 17 08:42 PM
Coastlands Capital LP10% OwnerNov 13 '26Buy0.50209,431103,7944,044,466Nov 17 08:42 PM
Coastlands Capital LP10% OwnerJun 17 '26Buy0.53100,00053,0003,835,035Jun 22 10:30 AM
STEINMAN LAWRENCEDirectorNov 28 '25Buy0.75133,333100,000199,691Dec 01 09:07 AM
Marques TiagoChief Executive OfficerNov 28 '25Buy0.7533,33325,00073,334Dec 01 08:56 AM
Dumesnil SimonDirectorNov 28 '25Buy0.7533,33325,00035,833Dec 01 08:54 AM
Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.
M.D.Dr. Lawrence Steinman BA
Ph.D.Dr. Tiago Reis Marques M.D.
Chief Financial OfficerMr. Daniel H. Schneiderman
Ph.D.Dr. Kartik Krishnan M.D.